Extractables and leachables (E&L) assessment is a critical part in product development strategy. Regulatory bodies are
very concerned about the interaction between pharmaceutical products and container closure systems, drug delivery
devices, as well bioprocess manufacturing systems. Therefore, the migration of mobile chemicals from components and
ingredients used in drug production and storage needs to be carefully evaluated.

Our online conference brings together scientists, toxicologists and managers to share the latest E&L analytical methods
and strategies, regulatory updates and compliance, risk-based E&L programs, chemical characterization and toxicological
risk assessment, material selection/screening/identification, uncertainty factors in E&L testing, analytical and safety
thresholds, medical device materials and ISO 10993-18, customized methods for specific product types.

Participate in our virtual meeting and equip yourself with new tools to analyze and test for extractables and leachables in
biopharmaceutical development – to effectively reduce E&L-related risks and ensure patient safety and product quality.